Nabriva Therapeutics plc (NBRV) Gained 9.38% or 0.18 To Price $2.1 On Tuesday

Nabriva Therapeutics plc (NBRV) gained 9.38% or 0.18 to $2.1. It is near to 1.02 million shares traded, which is 76.19% compare to the average total volume 1.34 million. The market cap of NBRV is $152.37 million. The year to date change is 23.66%. The 52 week price range is from $1.12 to $4.6. Price of NBRV have changed -17.95% during last week. It have changed -28.09% over last month, -20.00% over last 3 months, -8.13% over last 6 months and -56.06% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBRV is 2.54. It is 20.95% above current price. The 200-day Moving Averages for NBRV is 2.33. It is 10.95% above current price. The 52-week High is 4.6. It is 119.05% from the current price. The 52-week Low is 1.12. It is -46.67% from current price.

There are some statistics of NBRV. It is has market cap $152.37 million. The share outstanding is 72.56 million. The average volume is 1.34 million. The percent of top 15 Institution holding is 46.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBRV is -172.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBRV is -124.46%.


Share this post